Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) — Capital Reinvestment Ratio
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a Capital Reinvestment Ratio of 0.95x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥45.11 Million) in capital expenditures (CN¥42.81 Million). See net asset quality index of Shandong Bailong Chuangyuan Bio-Tech Co. to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Capital Reinvestment Ratio (2016–2025)
This chart tracks Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s Capital Reinvestment Ratio across 10 annual periods. Check 605016 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025. For live market cap and broader valuation context, see 605016 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.19x | CN¥135.45 Million | CN¥296.80 Million | ▲ +134.0% |
| 2024 | 0.94x | CN¥300.89 Million | CN¥281.81 Million | ▼ -41.6% |
| 2023 | 1.60x | CN¥194.63 Million | CN¥311.98 Million | ▲ +36.8% |
| 2022 | 1.17x | CN¥149.82 Million | CN¥175.60 Million | ▲ +102.0% |
| 2021 | 0.58x | CN¥96.20 Million | CN¥55.82 Million | ▲ +20.5% |
| 2020 | 0.48x | CN¥121.82 Million | CN¥58.66 Million | ▼ -45.4% |
| 2019 | 0.88x | CN¥64.08 Million | CN¥56.49 Million | ▼ -10.8% |
| 2018 | 0.99x | CN¥89.12 Million | CN¥88.11 Million | ▲ +206.0% |
| 2017 | 0.32x | CN¥113.47 Million | CN¥36.66 Million | ▼ -30.8% |
| 2016 | 0.47x | CN¥60.10 Million | CN¥28.08 Million | — |